Recombinant monoclonal antibody specially binds to human tumor antigen ERBB2. This human anti-ERBB2 antibody (C6H2) can be potencially used in the treatment of cancers.
Figure 1 TPL blocks ErbB2 heterodimerization in the absence and presence of ErbB ligand.
Sensitivity was defined as a growth inhibition rate of more than 20%.
Li, B., Meng, Y., Zheng, L., Zhang, X., Tong, Q., Tan, W., ... & Zhang, G. (2013). Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization. Cancer research, 73(21), 6471-6483.
Figure 2 TPL inhibits ErbB2 signaling in both trastuzumabsensitive and -resistant breast cancer cell lines.
Immunoblots examining the ability of 100 nmol/L of control IgG, trastuzumab, pertuzumab, trastuzumab plus pertuzumab, TTL, PPL, TTL plus PPL, or TPL to inhibit the phosphorylation of EGFR, ErbB2, ErbB3, AKT, and MAPK in BT-474 cells in the absence of ErbB ligand.
Li, B., Meng, Y., Zheng, L., Zhang, X., Tong, Q., Tan, W., ... & Zhang, G. (2013). Bispecific antibody to ErbB2 overcomes trastuzumab resistance through comprehensive blockade of ErbB2 heterodimerization. Cancer research, 73(21), 6471-6483.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-059 | Recombinant Anti-Human ERBB2 VHH Single Domain Antibody | IHC, FC, CA, FuncS | Llama VHH |
PNBL-066 | Recombinant Anti-HER2 VHH Single Domain Antibody (PNBL-066) | SPR | Llama VHH |
PNBL-067 | Recombinant Anti-HER2 VHH Single Domain Antibody (PNBL-067) | SPR | Llama VHH |
PNBL-069 | Recombinant Anti-HER2 VHH Single Domain Antibody (PNBL-069) | ELISA | Llama VHH |
HPAB-0201-FY | Recombinant llama Anti-ERBB2 Antibody (HPAB-0201-FY) | E | llama VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
IAB-B008(A) | Recombinant Anti-human ERBB2 Intrabody [(D-Arg)9] | IF, FC, FuncS | scFv-(D-Arg)9 |
IAB-B008(G) | Recombinant Anti-human ERBB2 Intrabody [+36 GFP] | WB, ICC, FuncS | scFv-(+36GFP) |
IAB-B008(T) | Recombinant Anti-human ERBB2 Intrabody [Tat] | ICC, Neut, FuncS | scFv-Tat |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-761 | Anti-ERBB2 Recombinant Antibody (Margetuximab) | IF, IP, Neut, FuncS, ELISA, FC, WB | IgG1 - kappa |
TAB-049CT | Anti-Human HER2/neu Recombinant Antibody (ChA21) | IHC, Inhib, WB, Activ, FC | Chimeric antibody (mouse/human) |
TAB-049CT-S(P) | Anti-Human HER2/neu Recombinant Antibody scFv Fragment (ChA21) | WB | Chimeric antibody (mouse/human) |
TAB-049CT-F(E) | Anti-Human HER2/neu Recombinant Antibody Fab Fragment (ChA21) | WB | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
AGTO-G022E | Anti-ERBB2 immunotoxin 4D5 (scFv)-PE | Cytotoxicity assay, Function study | |
AGTO-G022D | Anti-ERBB2 immunotoxin 4D5 (scFv)-DT | Cytotoxicity assay, Function study | |
AGTO-G022G | Anti-ERBB2 immunotoxin 4D5 (scFv)-Gel | Cytotoxicity assay, Function study | |
AGTO-G022R | Anti-ERBB2 immunotoxin 4D5 (scFv)-RTA | Cytotoxicity assay, Function study | |
AGTO-G022S | Anti-ERBB2 immunotoxin 4D5 (scFv)-Sap | Cytotoxicity assay, Function study |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-085 | Human Anti-ERBB2 Recombinant Antibody; scFv Fragment (PSBL-085) | ELISA, WB, FuncS | Human scFv |
FAMAB-0170JF-S(P) | Human Anti-ERBB2 Recombinant Antibody (clone C6VLF); scFv Fragment | ELISA, FuncS | Human scFv |
FAMAB-0171JF-S(P) | Human Anti-ERBB2 Recombinant Antibody (clone C6L1); scFv Fragment | ELISA, FuncS | Human scFv |
FAMAB-0172JF-S(P) | Human Anti-ERBB2 Recombinant Antibody (clone C6H2); scFv Fragment | ELISA, FuncS | Human scFv |
FAMAB-0173JF-S(P) | Human Anti-ERBB2 Recombinant Antibody (clone C6H211); scFv Fragment | ELISA, FuncS | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-033CT | Human Anti-ERBB2 Recombinant Antibody (TAB-033CT) | ELISA, WB | Human IgG1, κ |
TAB-050CT | Anti-Human HER2/neu Recombinant Antibody (HuA21) | Inhib, Cty, IHC, WB, IF, FC, ELISA | Humanized antibody |
TAB-053CT | Human Anti-ERBB2 Recombinant Antibody (TAB-053CT) | ELISA, Inhib, FC | Humanized IgG |
TAB-054CT | Humanized Anti-Human HER2/neu Recombinant Antibody | ELISA, Inhibition, FC | Humanized antibody |
TAB-041CT-S(P) | Human Anti-ERBB2 Recombinant Antibody; scFv Fragment (TAB-041CT-S(P)) | ELISA, WB | Humanized scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-034CT | Anti-Human HER2/neu Recombinant Antibody (pertuzumab ) | WB | |
TAB-036CT-S(P) | Anti-Human HER2/neu Recombinant Antibody scFv Fragment (6B2) | ELISA, WB | |
TAB-037CT-S(P) | Anti-Human HER2/neu Recombinant Antibody scFv Fragment (7C2/7F3) | ELISA, WB | |
TAB-270CQ | Mouse Anti-ERBB2 Recombinant Antibody (TAB-270CQ) | WB, Inhib | Mouse IgG |
TAB-270CQ-S(P) | Mouse Anti-ERBB2 Recombinant Antibody; scFv Fragment (TAB-270CQ-S(P)) | WB, Inhib | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-040CT-S(P) | Anti-Human HER2/neu Recombinant Antibody scFv Fragment (C6.5) | FC, IP, Block | Human antibody |
TAB-048CT-S(P) | Human Anti-ERBB2 Recombinant Antibody; scFv Fragment (TAB-048CT-S(P)) | ELISA, WB | Human scFv |
TAB-055CT-S(P) | Anti-Human HER2/neu Recombinant Antibody scFv Fragment | WB | Human antibody |
TAB-056CT-S(P) | Human Anti-ERBB2 Recombinant Antibody; scFv Fragment (TAB-056CT-S(P)) | WB | Human scFv |
PABX-081 | Recombinant Human Anti-HER2 Antibody (Gr3) | WB, ELISA, FuncS | IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-024LC | Recombinant Anti-Human ERBB2 Antibody (Fab glycosylation) | ELISA | Mouse antibody |
Gly-039LC | Recombinant Anti-Human ERBB2 Antibody (Fab glycosylation) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-117LC | Recombinant Anti-Human ERBB2 Antibody (Fc glycosylation) | ELISA | Humanized antibody |
Gly-118LC | Recombinant Anti-Human ERBB2 Antibody (Fc glycosylation) | ELISA | Mouse antibody |
Gly-145LC | Recombinant Anti-Human ERBB2 Antibody (Fc glycosylation) | ELISA | Human antibody |
Gly-146LC | Recombinant Anti-Human ERBB2 Antibody (Fc glycosylation) | ELISA | Human antibody |
Gly-147LC | Recombinant Anti-Human ERBB2 Antibody (Fc glycosylation) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
Gly-177LC | Recombinant Anti-Human ERBB2 Antibody (Non-glycosylated) | ELISA | Humanized antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0195MZ | Chicken Anti-ERBB2 Polyclonal IgY | WB | Chicken antibody |
BRD-0695MZ | Chicken Anti-ERBB2 Polyclonal IgY | WB | Chicken antibody |
BRD-0779MZ | Chicken Anti-ErbB2 Polyclonal IgY | ICC, IF, IHC, IP | Chicken antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
NEUT-737CQ | Mouse Anti-ERBB2 Recombinant Antibody (clone 7.16.4) | Block, IP, IF, FC | Mouse IgG2a |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1178 | Hi-Affi™ Rabbit Anti-ERBB2 Recombinant Antibody (clone DS1178AB) | IHC-P, IHC-Fr | Rabbit IgG |
MOR-4586 | Hi-Affi™ Rabbit Anti-ERBB2 Recombinant Antibody (clone TH99DS) | WB | Rabbit IgG |
MOR-4587 | Hi-Affi™ Rabbit Anti-ERBB2 Recombinant Antibody (clone TH100DS) | WB | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0091-FY | Human Anti-ERBB2 Recombinant Antibody (clone MIL12) | ELISA | Humanized IgG |
HPAB-0608LY | Human Anti-ERBB2 Recombinant Antibody (HPAB-0608LY) | ELISA, Inhib, WB, FC | Humanized IgG1 |
HPAB-0609LY | Human Anti-ERBB2 Recombinant Antibody (HPAB-0609LY) | ELISA, Inhib | Humanized IgG1 |
HPAB-1111LY | Mouse Anti-ERBB2 Recombinant Antibody (HPAB-1111LY) | IHC, FuncS, FC | Mouse IgG |
HPAB-1112LY | Human Anti-ERBB2 Recombinant Antibody (HPAB-1112LY) | ELISA | Chimeric (Mouse/Human) IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0608LY-F(E) | Human Anti-ERBB2 Recombinant Antibody; Fab Fragment (HPAB-0608LY-F(E)) | ELISA, Inhib | Humanized Fab |
HPAB-0609LY-F(E) | Human Anti-ERBB2 Recombinant Antibody; Fab Fragment (HPAB-0609LY-F(E)) | ELISA, Inhib | Humanized Fab |
HPAB-0610LY-F(E) | Human Anti-ERBB2 Recombinant Antibody; Fab Fragment (HPAB-0610LY-F(E)) | ELISA, Inhib | Humanized Fab |
HPAB-1111LY-F(E) | Mouse Anti-ERBB2 Recombinant Antibody; Fab Fragment (HPAB-1111LY-F(E)) | ELISA | Mouse Fab |
HPAB-1112LY-F(E) | Human Anti-ERBB2 Recombinant Antibody; Fab Fragment (HPAB-1112LY-F(E)) | ELISA | Chimeric (Mouse/Human) Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-468CQ | Afuco™ Anti-ERBB2 ADCC Recombinant Antibody (Timigutuzumab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, FuncS | ADCC enhanced antibody |
AFC-TAB-053 | Afuco™ Anti-ERBB2 ADCC Recombinant Antibody (Pertuzumab), ADCC Enhanced | FuncS, IF, Neut, ELISA, FC, IP | ADCC enhanced antibody |
AFC-TAB-761 | Afuco™ Anti-ERBB2 ADCC Recombinant Antibody (Margetuximab), ADCC Enhanced | IF, IP, Neut, FuncS, ELISA, FC | ADCC enhanced antibody |
AFC-TAB-005 | Afuco™ Anti-ERBB2 ADCC Recombinant Antibody (Trastuzumab), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | ADCC enhanced antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MHC-CN0641 | PE-A*02:01/Human ERBB2 (LIAHNQVRQV) MHC Tetramer | FCM, IHC | |
MHC-CN0642 | APC-A*02:01/Human ERBB2 (LIAHNQVRQV) MHC Tetramer | FCM, IHC | |
MHC-CN0643 | FITC-A*02:01/Human ERBB2 (LIAHNQVRQV) MHC Tetramer | FCM, IHC | |
MHC-CN0644 | A*02:01/Human ERBB2 (LIAHNQVRQV) MHC Tetramer | FCM, IHC | |
MHC-CN0645 | PE-A*02:01/Human ERBB2 (ILHDGAYSL) MHC Tetramer | FCM, IHC |
There are currently no Customer reviews or questions for FAMAB-0172JF. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.